{"name":"Conjupro Biotherapeutics, Inc.","slug":"conjupro-biotherapeutics-inc","ticker":"","exchange":"","domain":"conjuprobiotherapeutics.com","description":"Conjupro Biotherapeutics, Inc. is a biotechnology company focused on the development of novel biotherapeutics. The company has a pipeline of 10 drugs in early-stage clinical trials, primarily targeting cardiovascular and metabolic diseases.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOZThxQ3dkLXp0dkU2blM0RlM3TzZVZ3NZSWFiQVAxYURlb0ZRLUtlQ1ZyWUJjN3ZSb29PeTBrNFBnUm5iZ09tbG54d0tkb1I4TzBQOGJvVlhMeHRleHU0dDBqWUlwdTgzemw0c0hCemppZDFHejlFNUxXYXRFU1ltOXd5Ulk5MzZ6d0ZrSHViSG9JTE0yNnpFWk43dVRHeDDSAVZBVV95cUxNdHJZU0pFM3Z0SllJMnVOT1l2SzhsVDB0NXhsQnhsNFl5VngtdTBBN0FpV3lic19GbS01YXJqQ2loMU5UREt0WmJreEFrV2NBRkdiUnllQQ?oc=5","date":"2025-12-02","type":"pipeline","source":"Law360","summary":"Squires Institutes First PTAB Challenges Since Taking Over - Law360","headline":"Squires Institutes First PTAB Challenges Since Taking Over - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNTnF4d1pfRFoxd2xzNU8tVXB3azZ1a19YUGxEc0dQOXoxdU5TMjhxN0dRelBLZ184a25lYXlaWFhRQzFyMHpGRHVRd2tfT1RhVUIyNkJJbEQzMXd2M19FOFZpdzJDcjdjbEFwOFRXNV80ZHlWeV9wbHJEZklhTUhhTHA2MHRwMmllb1dBdEkxMVcyTUEtUm1WWU530gFWQVVfeXFMUDAzNXFwcl9LVHFCSnR4Tm5QalhDU2xfRm12ODVXdl8wTEF0aDRNQndJM0gtMlZxS29EZDNfUUxGY3ZSb2c2NEd0cE9ybWFNRjB5MHNGZ2c?oc=5","date":"2025-11-21","type":"pipeline","source":"Law360","summary":"Squires Issues 57 More PTAB Denials, Broken Out By Type - Law360","headline":"Squires Issues 57 More PTAB Denials, Broken Out By Type - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPSTIzR292ZjJlcW5SaFloNFFQa1lVZHdxTUFjOU9kRXhqNVBlN2pld09Gd2FESVVMeU1FcFZOczJocFA0X0d3NjBjVFJzTUJNSGRybGZ0S1dXczdpeGJ5QUpOS1FCRVdXZ2dEbzdTaklZbHdLQTJtem9aSzFKS0V0T0FWN2s4NHJjQUo1UTE5RXFQeEtF?oc=5","date":"2025-06-16","type":"pipeline","source":"BioWorld News","summary":"Astrazeneca makes $5.3B drug R&D pact with CSPC - BioWorld News","headline":"Astrazeneca makes $5.3B drug R&D pact with CSPC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVGhudTlQdmVrczBXOEY2Z3pDTmNKSWhVNXZvM3Jka1Y3VkhKMFdZYzIyaE9fb240SklNeVhWWWppRFhERWNOZ0FSQ2d6eU9zc2JaWmdqMWdkc1Nub1pXOHk5dkpGNk1kcXJkbjJBVzZGS041dkg1ODJsYUxCOGE2bkMzMzF2RUgyTlFsZXQtOFU2VFdPenk4dzBYQ0FoVl9wWnhMT1RZSm8zZw?oc=5","date":"2025-06-10","type":"deal","source":"BioWorld News","summary":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock - BioWorld News","headline":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNUzlzSlk3cmU0TDJXcW5lRkZqV1cwTExJeVpCemowOVhINjlIX0N2RGlqYm5kbV9wVDhjYk9GTkNuWU12Ml9scXFfMUpXaF9pWGszVVRsamhPOWFTa3plb2F4OG9IMVQ4YTJ3c09LeWxLbkdPWGhQVEo3NjNuM0FBMzIwRzRIV1BsMWUwMXJUZXo2OEcyeUZaYzlvVVctYXp0YU1QRmduaw?oc=5","date":"2025-05-30","type":"deal","source":"BioWorld News","summary":"CSPC hints at three upcoming deals worth $5B for EGFR ADC, others - BioWorld News","headline":"CSPC hints at three upcoming deals worth $5B for EGFR ADC, others","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxQLUdGNExlVk1Yb25WMVhZWUlQUzgteV93WGRaSHU4WWZzMDFUYURLQXV5dFdHM3JTcERzSVQ5eUlLOFRSTXFsak8xdFJ4RmpHblB6YXJWY0tXMnhrQWluUk5OTkRqWTZvWHB0UkUyMndISW9XSS1tNDhnTDVnZmVxZm1lWUVLM3VVb2Y0dzJ2ZDExNWlhNk84RERxRkJSY2RubzhfSHZPZ3JpQ1NhSWV3ODltTlc3TF9ZWlV4LXFNWV9EdFlOT1RQNnFGeVotT3l3LWhmd2Z1Y19DcmtfQzJqdDlSaFlsZWJhWmlPMVluVkIzTmRPcTQxcDZ1UkhicGVfQUFqZ3QtZHVfTEQ1RXB4UmFkVkRmeXduUU1XQzM2YU5Jb002cnNpb01B?oc=5","date":"2024-11-28","type":"trial","source":"PR Newswire","summary":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQOTFNRmFOVjV3QnVlYzU5Yzhab0FEdDNpb1BiSWl6em8yUGZ5eVNveWRuMlpvNEZZTF9fR001Qmw1dFpWMEtHS2xkQUU2MkZDdVFta3pSMXdSVXhwZkdtLUg4d0NOX1NLa3Z0M0NBZnJ2Z0JvTk5kd3QzdU45N3Vqem1zX0xlSFpQQ2lBRXdFZ20xQ0NkclVRSG9odTBULTd2WVBXbEZRdkY5VHVrcWtjVXc4WXZXRzBIZzdGN2xaX2o0YWZaNUkyY0JvcWdDZ1NNZDBGVnJ5Mkc0M0k3azRiXzM0a0JRYmdQNkRLRzJqZFE0QUFQcW5WdVNYTHZKb19CQUxncW5pbEl6S2QtUWNSQnVVWGdsUQ?oc=5","date":"2024-10-21","type":"regulatory","source":"GlobeNewswire","summary":"Allogeneic Hematopoietic Stem Cell Transplant Market to - GlobeNewswire","headline":"Allogeneic Hematopoietic Stem Cell Transplant Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOMmxuZHV2Y0NBN2xkdUhteE9TSEh2VWxEd2tlaTFPTHZ4aUVtczF3OUFNVThSZWg2SEctX2U0d1lKLWI5cE93UGxTODk0Qnk3dl9BQ1JRZmJZZlNmd2MwS2VFbWF4OXp2cjFyNnFCTUlJdl9aeE1WcVNDQU5UcmpqTlRrcmRGclZlbG43eUNiQi1maXJ1Z3JnQ1NnNVBGUQ?oc=5","date":"2024-08-26","type":"pipeline","source":"Bloomberg Law News","summary":"Ipsen Sues CSPC Pharma to Block Branded Rival to Cancer Drug - Bloomberg Law News","headline":"Ipsen Sues CSPC Pharma to Block Branded Rival to Cancer Drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}